DiscoverJAMA Oncology Author InterviewsIntracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy
Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Update: 2025-01-30
Share

Description

Interview with Michael A. Postow, MD, author of Intracranial Outcomes of Ipilimumab and Nivolumab in Melanoma Brain Metastases After Progression on Anti–PD-1 Therapy. Hosted by Vivek Subbiah, MD.

Related Content:

Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy

Intracranial Outcomes in Melanoma Brain Metastases After Anti–PD-1 Therapy